U.S. Markets closed

MitraClip Drives Growth, Gets Reimbursement Approval in Japan

Sarah Collins
MitraClip Drives Growth, Gets Reimbursement Approval in Japan

On March 19, 2018, Abbott Laboratories (ABT) announced that it had received reimbursement approval for its MitraClip device in Japan. MitraClip is a minimally invasive procedure for patients suffering from MR (mitral regurgitation) who are at high risk of open surgery.